We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 48

Health care, employers, confusion, and controversy
  • Wiley Rein LLP
  • USA
  • March 14 2014

The recent controversy about AOL CEO Tim Armstrong's comments on employee health care expenses reflects ongoing confusion about the rules for


FTC agreement adds to the accretive health enforcement saga
  • Wiley Rein LLP
  • USA
  • January 17 2014

On New Year's Eve, the Federal Trade Commission (FTC) announced a consent order settlement with Accretive Health, Inc., purporting to address the


HIPAAHITECH compliance is finally here
  • Wiley Rein LLP
  • USA
  • September 17 2013

More than four and a half years since the passage of the Health Information Technology for Economic and Clinical Health (HITECH) Act, the time for


The new HIPAAHITECH era is finally here
  • Wiley Rein LLP
  • USA
  • February 12 2013

After almost four years, the Department of Health and Human Services finally has released its omnibus Health Insurance Portability and Accountability


The FTC imposes data security obligations on a cord blood bank
  • Wiley Rein LLP
  • USA
  • February 12 2013

The Federal Trade Commission (FTC or Commission) announced on January 28 that it had reached a settlement with Cbr Systems, Inc. as "part of the


Unfinished business: solving the HIPAA accounting rule dilemma
  • Wiley Rein LLP
  • USA
  • May 9 2013

Now that the Health Information Technology for Economic and Clinical Health (HITECH) rules finally have been released, health care companies and


FDASIA report proposes rules of the road for Health IT
  • Wiley Rein LLP
  • USA
  • April 7 2014

The long awaited FDASIA Health IT Report proposes a strategy for calibrating regulatory oversight to risk and clarifying the regulatory obligations


FDA clarifies which mhealth apps require pre-market notification as medical devices
  • Wiley Rein LLP
  • USA
  • September 30 2013

On September 25, 2013, the U.S. Food and Drug Administration (FDA) issued its much-anticipated Final Guidance for Industry on Mobile Medical


Update on Health IT efforts under the American Recovery and Reinvestment Act
  • Wiley Rein LLP
  • USA
  • June 4 2009

For health care providers, technology developers, and medical insurers, the standards under which Health Information Technology (Health IT) will function will spell cost recovery, profit, or unreimbursed expense


Security risks from insiders
  • Wiley Rein LLP
  • USA
  • June 5 2009

Two recent incidents demonstrate dramatically and publicly one of the biggest security risks facing the health care industry and others across corporate Americathe risk of insider misuse of data access